Kuyaş HEKİMLER ÖZTÜRK

Kuyaş HEKİMLER ÖZTÜRK

Auto-generated profile, based on publicly available information

Kuyaş HEKİMLER ÖZTÜRK

Department of Medical Genetics, Faculty of Medicine Suleyman Demirel University Isparta Turkey

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2022 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
KÖKuyaş Hekimler Öztürk
Kuyaş Hekimler Öztürk
GÜGülin Özdamar Ünal
Gülin Özdamar Ünal
DDDuygu Kumbul Doğuç
Duygu Kumbul Doğuç
VTVehbi Atahan Toğay
Vehbi Atahan Toğay
PKPınar Aslan Koşar
Pınar Aslan Koşar
MSMekin Sezik
Mekin Sezik

24 October 2019 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
BFBaşak FİLİZ
Başak FİLİZ
MYMehmet Yildirim
Mehmet Yildirim
KÖKuyaş HEKİMLER ÖZTÜRK
Kuyaş HEKİMLER ÖZTÜRK
FŞFevziye Burcu Şi̇rİn
Fevziye Burcu Şi̇rİn
SÇSeda Çeli̇k
Seda Çeli̇k
HOHikmet Orhan
Hikmet Orhan
IL-23R gene polymorphisms and the association of these polymorphisms with serum IL-23 levels were investigated in patients with psoriasis in the current study. Sixty-seven patients with psoriasis who were admitted to our dermatology outpatient clinic and 67 healthy controls were included in the study. Polymorphisms of the IL-23R gene were determined by KASP-PCR method, and serum IL-23 levels were determined by ELISA method. The distribution of IL-23R gene polymorphisms rs2201841, rs11209026, rs7530511, rs1343152, and rs11465804 was not significantly different in the patient and control groups. The AA genotype of the rs2201841 locus in males and the GA genotype in females, as well as the AA genotype of the rs1343152 locus in males and the CA genotype in females, were statistically significant in patients with psoriasis. The mean serum IL-23 level was significantly lower in the patient group (42.62 ± 5.96) compared to the control groups (75.76 ± 13.24). IL-23R gene polymorphisms including rs2201841, rs11209026, rs7530511, rs11465804, and rs1343152 were not found to be significantly related to psoriasis. Different genetic polymorphisms may play a role in the development of psoriasis in female and male populations. Ethnic differences between different populations may have led to differences in the distribution of polymorphisms in the current study with compared to other published studies. Additionally, many different genes, polymorphisms, and environmental factors that have an effect on the development of psoriasis may affect the disease process.

6 August 2022 in International Journal of Psychiatry in Clinical Practice
Verified
Journal Article
Closed access
GUGulin Ozdamar Unal
Gulin Ozdamar Unal
KOKuyas Hekimler Ozturk
Kuyas Hekimler Ozturk
HIHuseyin Emre Inci
Huseyin Emre Inci
This study aimed to evaluate the gene expression of the P2X purinoceptor 7 (P2X7R)- nod-like receptor pyrin domain-containing protein 3 (NLRP3) signal pathway in peripheral blood mononuclear cells ...

16 March 2022 in International Journal of Developmental Neuroscience
Verified
Journal Article
Closed access
GÜGülin Özdamar Ünal
Gülin Özdamar Ünal
KÖKuyaş Hekimler Öztürk
Kuyaş Hekimler Öztürk
GEGamze Erkilinc
Gamze Erkilinc
FDFeyza Dönmez
Feyza Dönmez
DDDuygu Kumbul Doğuç
Duygu Kumbul Doğuç
MSMekin Sezik
Mekin Sezik

29 January 2024 in Immunopharmacology and Immunotoxicology
Verified
Journal Article
Closed access
GUGulin Ozdamar Unal
Gulin Ozdamar Unal
DKDuygu Kumbul
Duygu Kumbul
KOKuyas Hekimler Ozturk
Kuyas Hekimler Ozturk
GEGamze Erkilinc
Gamze Erkilinc
FDFeyza Donmez
Feyza Donmez
RYRamazan Oğuz Yüceer
Ramazan Oğuz Yüceer
Increasing evidence suggests that early life stress (ELS) and neuroinflammation are associated with the pathophysiology of depression. The purpose of this study was to determine the effects of Vortioxetine (VOR), a novel antidepressant, on ELS-induced behavioral changes and neuroinflammation. Wistar Albino 4-week-old male rats were divided into four groups: control; chronic unpredictable stress (CUMS), VOR, CUMS + VOR. Neurobehavioral assessment was performed on the first, 21st, and 42nd days. RT-PCR was used to detect the expression of P2X7, NLRP3, IL1β, IL18 in the prefrontal cortex. To assess the microglial activities of the prefrontal cortex, immunohistochemically stained CD68, and leukocyte common antigen (LCA) preparations were scanned with Manual WSI software, Basler camera, and scored. Exposure to CUMS was associated with depression and anxiety-like behaviors, and administration of VOR led to improvement in these behaviors. NLRP3, IL-1β, and IL-18 were shown to be upregulated in the prefrontal cortex of CUMS rats, while their high expression was inhibited by VOR treatment. CD68 and LCA expressions were significantly higher in the CUMS group compared to the other groups. According to these results, it may be considered that NLRP3 inflammasome-associated neuroinflammatory response and microglial activation may play a role in the etiopathogenesis of ELS.

30 August 2021 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
HKHakan Korkmaz
Hakan Korkmaz
KÖKuyaş HEKİMLER ÖZTÜRK
Kuyaş HEKİMLER ÖZTÜRK
BTBora Torus
Bora Torus
MiRNAs control various biological functions such as cell proliferation, differentiation, signaling pathways, apoptosis and metabolism. Recently, it has been shown that there is a relationship between changes in miRNA expression and the development of acromegaly. Studies are needed to identify new disease-specific miRNAs. The aim of the current study is to evaluate plasma miR-29c-3p, miR-31-5p and miR-18a-5p steady-state levels in acromegaly. Another aim is to investigate whether there is a difference in the levels of these miRNAs in patients with inadequate control and controlled acromegaly with somatostatin analog (SSA) therapy. These miRNAs targeting the IGF-1 gene were determined by in silico estimation. The study included 30 healthy controls (HC) and 20 patients with acromegaly. Anterior pituitary functions and disease activities of patients with acromegaly were evaluated at the time of study. The miR-29c-3p, miR-31-5p and miR-18a-5p levels were measured using quantitative Real-Time PCR (RT-qPCR). The expression level of miR-29c-3p was significantly lower in patients with acromegaly compared to the HC group (p<0.001). This downregulation was more pronounced in patients with inadequately controlled acromegaly than in patients with acromegaly controlled with SSA therapy (p=0.016). Univariate logistic regression analysis results showed that down regulation of miR-29c-3p expression increases the risk of developing acromegaly [OR (95% Cl)=1.605 (1.142-2.257), p=0.006]. There was no significant difference between the groups in terms of miR-31-5p and miR-18a-5p expression levels (p=0.375 and p=0.649, respectively). Plasma miR-29c-3p expression level is downregulated in patients with acromegaly, and this is more pronounced in patients with inadequate control.